Authors/Disclosures
|
Fabrizio Stocchi
|
Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion. |
|
Fawaz Al-Mufti, MD
(Westchester Medical Center at New York Medical College)
|
Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio . |
|
David J. Brooks, MD, DSc, FRCP
(Imperial College London)
|
No disclosure on file |
|
Jonathan P. Hosey, MD, FAAN
|
Dr. Hosey has nothing to disclose. |
|
|
No disclosure on file |
|
Tommy B. Tsang
|
No disclosure on file |
|
Eldad Melamed, MD
(Rabin Medical Ctr Beilinson Campus)
|
No disclosure on file |
|
Rolla Nuoman, MD
(BCHP Pediatric Neurology Specialty at Saw Mill River Road)
|
Dr. Nuoman has nothing to disclose. |
|
|
No disclosure on file |
|
Wolfgang H. Oertel, MD, FAAN
(Philipps-University Marburg)
|
Dr. Oertel has received personal compensation for serving as an employee of ParkinsonFonds Deutschland. Dr. Oertel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IntraBio, UK. Dr. Oertel has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for MODAG Germany. The institution of Dr. Oertel has received research support from Stichting ParkinsonFonds, The Netherlands,. The institution of Dr. Oertel has received research support from Michael J Fox Foundation. |
|
Mohammad H. El-Ghanem, MD
(Neuroendovascular Surgery - Northwest Medical Center)
|
Dr. El-Ghanem has nothing to disclose. |
|
Werner Poewe, MD
(University Hospital of Neurology)
|
Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities. |
|
Chirag Gandhi
(Westchester Medical Center)
|
Chirag Gandhi has nothing to disclose. |
|
Olivier Rascol, MD, PhD
(Departments of Clinical Pharmacology and Neurosciences-CIC9302/INSERM 825)
|
Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020). |
|
Eduardo S. Tolosa, MD
|
Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prevail. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MSD . Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie . Dr. Tolosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ever Neuropharm. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esteve. The institution of Dr. Tolosa has received research support from Instituto de Salud CArlos III. Dr. Tolosa has received research support from MJFF. Dr. Tolosa has received publishing royalties from a publication relating to health care. |
|
Glenn T. Stebbins, PhD
(Rush University Medical Center)
|
Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS. |